Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Elvin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Cell Communication and Signaling|December 17, 2017
CCN5/WISP2 and metabolic diseasesJohn R Grünberg, Johannes Elvin, Alexandra Paul, et al.
Plos One|February 6, 2014
Effects of melanocortin 1 receptor agonists in experimental nephropathiesAnnika Lindskog Jonsson, Anna Granqvist, Johannes Elvin, et al.
BMC Nephrology|April 6, 2016
Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1Kerstin Ebefors, Peidi Liu, Emelie Lassén, et al.
American Journal of Physiology. Renal Physiology|February 19, 2016
Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activationJohannes Elvin, Lisa Buvall, Annika Lindskog Jonsson, et al.
Scientific Reports|October 26, 2018
Amplification of the Melanocortin-1 Receptor in Nephrotic Syndrome Identifies a Target for Podocyte Cytoskeleton StabilizationLovisa Bergwall, Hanna Wallentin, Johannes Elvin, et al.
Scientific Reports|February 28, 2017
Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistanceJohn R Grünberg, Jenny M Hoffmann, Shahram Hedjazifar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Cell Communication and Signaling|December 17, 2017
CCN5/WISP2 and metabolic diseasesJohn R Grünberg, Johannes Elvin, Alexandra Paul, et al.
Plos One|February 6, 2014
Effects of melanocortin 1 receptor agonists in experimental nephropathiesAnnika Lindskog Jonsson, Anna Granqvist, Johannes Elvin, et al.
BMC Nephrology|April 6, 2016
Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1Kerstin Ebefors, Peidi Liu, Emelie Lassén, et al.
American Journal of Physiology. Renal Physiology|February 19, 2016
Melanocortin 1 receptor agonist protects podocytes through catalase and RhoA activationJohannes Elvin, Lisa Buvall, Annika Lindskog Jonsson, et al.
Scientific Reports|October 26, 2018
Amplification of the Melanocortin-1 Receptor in Nephrotic Syndrome Identifies a Target for Podocyte Cytoskeleton StabilizationLovisa Bergwall, Hanna Wallentin, Johannes Elvin, et al.
Scientific Reports|February 28, 2017
Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistanceJohn R Grünberg, Jenny M Hoffmann, Shahram Hedjazifar, et al.
Pageof 1